Navigation Links
Influenza vaccination during pregnancy protects newborns
Date:6/22/2011

WINSTON-SALEM, N.C. June 23, 2011 Infants born to mothers who received the influenza (flu) vaccine while pregnant are nearly 50 percent less likely to be hospitalized for the flu than infants born to mothers who did not receive the vaccine while pregnant, according to a new collaborative study by researchers at Wake Forest Baptist Medical Center and colleagues.

The Advisory Committee on Immunization Practices (ACIP) recommends influenza vaccination for anyone older than 6 months of age, but specifically singles out target groups, including pregnant women, who have a greater risk of influenza-related complications.

"It is recommended that all pregnant women receive the influenza vaccine during pregnancy because it is known that pregnant women have increased morbidity and mortality during pregnancy and in the immediate postpartum period if they get the flu," said Katherine A. Poehling, M.D., MPH., an associate professor of pediatrics and lead author on the study. "We also know that mothers pass antibodies through the placenta to the baby. This study showed us that receiving the influenza vaccine during pregnancy not only protects the mother, but also protects the baby in the early months of life."

The study, which is the first population-based, laboratory-confirmed study to demonstrate this benefit, appears in the June issue of the American Journal of Obstetrics & Gynecology.

Infants less than 6 months of age have the highest rates of flu hospitalization among all children, Poehling explained, yet the influenza vaccine is not licensed for or effective in infants that young.

So Poehling and colleagues sought to assess whether receiving the vaccine during pregnancy would provide some protection for the newborn baby.

The researchers analyzed data collected by the Centers for Disease Control and Prevention-funded New Vaccine Surveillance Network over the course of seven flu seasons between 2002 and 20
'/>"/>

Contact: Jessica Guenzel
jguenzel@wakehealth.edu
336-716-3487
Wake Forest Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Migratory birds, domestic poultry and avian influenza
2. InDevR awarded $3 million grant from NIH for influenza-related research
3. Influenza virus strains show increasing drug resistance and ability to spread
4. Hong Kong hospital reports possible airborne influenza transmission
5. NIH scientists explore 1510 influenza pandemic and lessons learned
6. Cell symposia meeting, Influenza: Translating basic insights, to be held Dec. 2-4, 2010
7. NIH-funded scientists find 2009 H1N1 pandemic influenza vaccine protects mice from 1918 flu virus
8. Mount Sinai researchers approaching universal treatment for all strains of influenza
9. Mount Sinai researchers move closer to a universal influenza vaccine
10. H1N1 influenza hits older children
11. Fear of pandemic influenza clogs EDs even when disease is not present
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... offer a new way to detect and treat autism during ... months of life, when the brain is ... agree that,the earlier autism is diagnosed and therapy begun, the ... even when parents have an intuition,that "something is amiss" with ...
... Low Fat, Rich and Creamy Beverage ... FULLERTON, Calif., March 11 Wildwood Organics, a,division of ... today launched Probiotic Soymilk(TM). This delicious beverage is,certified organic, ... of soy protein per serving. Probiotic Soymilk(TM) is also ...
... a global,leader in dental and aesthetic lasers, today ... tissue lasers will receive a,tuition-free introductory laser certification ... dental laser education. The partnership is,the latest milestone ... education., "We fully recognize that training is ...
... and Phase II Trials, with Some Patients Already Past the Expected Median Average ... Survival Time for This Population -, - Data From Dosimetry Trial ... ... March 11 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company developing ...
... March 10 As a longtime resident of Southern,Nevada, ... who have been,affected by this situation. I understand that ... against me and the Endoscopy Center of,Southern Nevada. While ... I,am unfortunately unable to do so at this time ...
... N.C., March 10 Cogdell Spencer,Inc. (NYSE: CSA ... 100,percent of the stock of Marshall Erdman and Associates. ... integrated healthcare real estate,company in the country, with over ... on January 23, 2008, was financed,through a $100 million ...
Cached Medicine News:Health News:Autism Awareness Month - New Hope for Detecting/Reversing Autism in Infants 2Health News:Wildwood Organics Introduces Probiotic Soymilk(TM) 2Health News:HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry 2Health News:Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials 2Health News:Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials 3Health News:Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials 4Health News:Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials 5Health News:Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials 6Health News:Cogdell Spencer Inc. Announces the Closing of the Marshall Erdman and Associates Merger 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... January 11, 2012 Simbionix USA Corporation, ... training, is pleased to announce that advanced virtual reality ... in addition to English. The new languages ... system, MentorLearn™. MentorLearn is available either as the new ...
... 11, 2012  Suneva Medical, a privately-held aesthetic medical device ... study to investigate the efficacy of Artefill for the ... being conducted at 10 centers throughout the U.S. and ... "Acne can have lasting effects on a patient,s ...
Cached Medicine Technology:Simbionix Comprehensive Medical Simulators now Available in Additional Languages 2Suneva Medical to Pursue Expanded Indications for ArtefillĀ® With Launch of Phase III Acne Scar Study 2
Standard knife with box, C profile...
... The Cryostage freezing stage is a refrigerated ... object holder, primarily for use with the 8000 ... other sledge microtomes. ,The refrigerated stage gives a ... the surface is ridged to provide good adhesion ...
... necessary to cool a specimen below room temperature. ... most microtomes and will permit specimen cooling from ... The equipment consists of a cooling stage and ... suited for operation with a base sledge microtome, ...
... MNL 4404 & 4405 series Freezing Stages fit ... have no moving parts and need only the ... for operation. Freezing starts immediately and ... adjustable so that optimum cutting temperatures can be ...
Medicine Products: